We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Zhiyi Pharmaceutics Stock

Invest in or calculate the value of your shares in Zhiyi Pharmaceutics or other pre-IPO companies through EquityZen's platform.

Get Started

Zhiyi Pharmaceutics Stock (ZHPH)

Zhiyi Pharmaceutics focuses on the research and development of second-generation probiotics and Live Biotherapeutics.

About Zhiyi Pharmaceutics Stock

Founded

2013

Industries

Science and Engineering, Health Care, Biotechnology

Founded in 2013, Zhiyi Bio focuses on the research and development of second-generation probiotics and Live Biotherapeutics. Based on the discovery of strains and drug development with independent intellectual property rights, a lot of innovative research has been carried out, and the “Know-How” from strains to drugs has been established, and the innovative live bacteria drug SK08 is about to enter the clinic. On this basis, Zhiyi will continue to strengthen the research and development of the relationship between human microbiome and disease, including microbial culture group and pathobionts research, target determination and separation of new functional strains.

Zhiyi Pharmaceutics Management

Leadership team at Zhiyi Pharmaceutics

Chief Executive Officer & Founder

Ye Wang

Locked Features

Join now and verify your accreditation status to gain access to:

  • Zhiyi Pharmaceutics current valuation
  • Zhiyi Pharmaceutics stock price
  • Available deals in Zhiyi Pharmaceutics and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Zhiyi Pharmaceutics stock?

Accredited investors can buy pre-IPO stock in companies like Zhiyi Pharmaceutics through EquityZen funds. These investments are made available by existing Zhiyi Pharmaceutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Zhiyi Pharmaceutics stock?

Shareholders can sell their Zhiyi Pharmaceutics stock through EquityZen's private company marketplace. EquityZen's network includes over 320K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."